USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
U.S. Inherited Disease Molecular Diagnostics Markets
U.S. Inherited Disease Molecular Diagnostics Markets
RELEASE DATE
16-Jul-2010
16-Jul-2010
REGION
North America
North America
Research Code: N790-01-00-00-00
SKU: HC02151-NA-MR_07739
$4,950.00
Special Price $3,712.50 save 25 %
In stock
SKU
HC02151-NA-MR_07739
Description
This research service analyzes the market for the inherited disease molecular diagnostics markets. FDA-cleared genetic tests for CF and inherited thrombophilia are included. Key market drivers and restraints are ranked and discussed. Key technology and trends that will impact the market are identified. Revenue forecasts, a market share analysis, and a product analysis are also provided. The competitive structure is provided for cystic fibrosis test vendors, inherited thrombophilia test vendors, and laboratories that offer of cystic fibrosis testing. The major market challenges are outlined along with strategic recommendations to address them.
Table of Contents
Market Overview
- Introduction
Market Overview
- Introduction
- Scope and Segmentation
- Research Methodology
- Market Engineering Measurements
Market Challenges and Strategic Recommendations
- Industry Challenges
- Strategic Recommendations
Market Drivers and Restraints
- Market Drivers
- Market Restraints
Technology and Market Trends
- Technology and Market Trends
Market Forecasts and Competitive Analysis
- Revenue Forecasts
- Competitive Structure - Cystic Fibrosis Test Vendors
- Competitive Structure - Cystic Fibrosis Test Services
- Competitive Structure - Inherited Thrombophilia Test Vendors
- Market Share Analysis - Cystic Fibrosis Test Vendors
- Market Share Analysis - Inherited Thrombophilia Test Vendors
- Product Analysis - Inherited Disease Molecular Diagnostics Tests and Platforms
- Product Analysis - Cystic Fibrosis Tests
- Product Analysis - Inherited Thrombophilia Tests
This research service analyzes the market for the inherited disease molecular diagnostics markets. FDA-cleared genetic tests for CF and inherited thrombophilia are included. Key market drivers and restraints are ranked and discussed. Key technology and trends that will impact the market are identified. Revenue forecasts, a market share analysis, and a product analysis are also provided. The competitive structure is provided for cystic fibrosis test vendors, inherited thrombophilia test vendors, and laboratories that offer of cystic fibrosis testing. The major market challenges are outlined along with strategic recommendations to address them.
| No Index | Yes |
|---|---|
| Podcast | No |
| Industries | Healthcare |
| WIP Number | N790-01-00-00-00 |
| Is Prebook | No |